CD8A and hepatocellular carcinoma: Galarreta et al. reported that in a hepatocellular carcinoma (HCC) model the activation of β-catenin pathway can inhibit the recruitment of dendritic cells in TME, thereby inhibiting T cell activation and reducing the infiltration of CD8 + T cells.